Medication info

Pine Injection 5,000 IU/mL (Sodium Heparin)

Prescription medicationIntravenous injection · Subcutaneous injection
Ingredient · strength
Heparin Sodium›Strength being verified
Manufacturer / importer
Huons Co., Ltd.
Appearance
A transparent liquid that is colorless to pale yellow contained in a brown vial
Packaging
5 milliliters × 10 vials
Approval status
Active

MFDS item code 199903186 · Notified 1999.07.05 · Insurance code 670602351

Summary

Main use
Prevention and treatment of thrombosis and embolism; diagnosis and treatment of coagulation disorders; prevention of blood coagulation
Who receives it
Adults
Adult administration
It is usually administered by intravenous injection or added to the perfusion blood during extracorporeal circulation. The effect occurs immediately after administration, but heparin sensitivity varies considerably among individuals. Therefore, perform a heparin sensitivity test before administration and measure the blood coagulation time afterward to determine the maintenance dose. After administration, blood coagulation time is usually maintained at 15 ~ 20 minutes or longer, but the dose is determined according to the individual case, indication, or purpose. 1. Extracorporeal circulation 1) Artificial kidney (1) Systemic heparinization: Before starting dialysis, administer 1,000 ~ 5,000 IU as heparin sodium. After dialysis begins, administer an additional 500 ~ 1,500 IU per hour continuously or intermittently every hour. (2) Regional heparinization: Administer 1,500 ~ 2,500 IU per hour of this product continuously, and neutralize with protamine sulfate during perfusion in the body. 2) Blood perfusion with a heart-lung machine : Administer 150 ~ 300 IU of this product per kg of body weight, and add an appropriate amount as needed as the duration of extracorporeal circulation is extended. After extracorporeal circulation, use protamine sulfate to prevent postoperative bleeding and neutralize the effects of heparin. 2. Intravenous drip infusion Dissolve 10,000 ~ 30,000 IU of this product in 1,000 mL of 5 % glucose injection, normal saline injection, or Ringer's solution and infuse at a rate of approximately 30 drops per minute. When the whole blood coagulation time is 2 ~ 3 times the pre-dose value, administer by drip infusion at approximately 20 drops per minute. 3. Intermittent intravenous injection Administer 5,000 ~ 10,000 IU of this product intravenously every 4 ~ 8 hours. Starting 3 hours after initiating administration, measure the whole blood coagulation time every 2 ~ 4 hours and adjust the dose to maintain it at 2 ~ 3 times the pre-dose value. 4. Subcutaneous injection Administer 10,000 ~ 20,000 IU of this product subcutaneously, followed by a maintenance dose of 15,000 ~ 20,000 IU every 12 hours. Use a different injection site each time to prevent hematoma. 5. Blood transfusion and blood testing For blood transfusion, 400 ~ 500 IU of this product is usually used per 100 mL of blood; for blood testing, use 100 IU per 20 ~ 30 mL of blood.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Prevention and treatment of thrombosis and embolism; diagnosis and treatment of coagulation disorders; prevention of blood coagulation

  • Thrombosis
  • pulmonary embolism
  • thromboembolic atrial fibrillation
  • coagulopathy
  • blood coagulation
  • cerebral thrombosis
  • coronary artery occlusion
  • peripheral vascular embolism
View approved original text

This medication is used for the prevention and treatment of thrombosis and pulmonary embolism. It is particularly effective for the prevention and treatment of thrombosis that may occur after surgery and thromboembolic atrial fibrillation. It also helps diagnose and treat acute and chronic coagulopathies, and prevents blood coagulation during vascular and cardiac surgeries. Additionally, it is used for the prevention of cerebral thrombosis due to cerebral hemorrhage, and aids in preventing blood coagulation during transfusions, extracorporeal circulation, and dialysis. Moreover, it is effective for the treatment of coronary artery occlusion and peripheral vascular embolism accompanying acute myocardial infarction. This medication is used to prevent and treat various blood coagulation-related disorders.

How it is given

Adult administration

It is usually administered by intravenous injection or added to the perfusion blood during extracorporeal circulation. The effect occurs immediately after administration, but heparin sensitivity varies considerably among individuals. Therefore, perform a heparin sensitivity test before administration and measure the blood coagulation time afterward to determine the maintenance dose. After administration, blood coagulation time is usually maintained at 15 ~ 20 minutes or longer, but the dose is determined according to the individual case, indication, or purpose. 1. Extracorporeal circulation 1) Artificial kidney (1) Systemic heparinization: Before starting dialysis, administer 1,000 ~ 5,000 IU as heparin sodium. After dialysis begins, administer an additional 500 ~ 1,500 IU per hour continuously or intermittently every hour. (2) Regional heparinization: Administer 1,500 ~ 2,500 IU per hour of this product continuously, and neutralize with protamine sulfate during perfusion in the body. 2) Blood perfusion with a heart-lung machine : Administer 150 ~ 300 IU of this product per kg of body weight, and add an appropriate amount as needed as the duration of extracorporeal circulation is extended. After extracorporeal circulation, use protamine sulfate to prevent postoperative bleeding and neutralize the effects of heparin. 2. Intravenous drip infusion Dissolve 10,000 ~ 30,000 IU of this product in 1,000 mL of 5 % glucose injection, normal saline injection, or Ringer's solution and infuse at a rate of approximately 30 drops per minute. When the whole blood coagulation time is 2 ~ 3 times the pre-dose value, administer by drip infusion at approximately 20 drops per minute. 3. Intermittent intravenous injection Administer 5,000 ~ 10,000 IU of this product intravenously every 4 ~ 8 hours. Starting 3 hours after initiating administration, measure the whole blood coagulation time every 2 ~ 4 hours and adjust the dose to maintain it at 2 ~ 3 times the pre-dose value. 4. Subcutaneous injection Administer 10,000 ~ 20,000 IU of this product subcutaneously, followed by a maintenance dose of 15,000 ~ 20,000 IU every 12 hours. Use a different injection site each time to prevent hematoma. 5. Blood transfusion and blood testing For blood transfusion, 400 ~ 500 IU of this product is usually used per 100 mL of blood; for blood testing, use 100 IU per 20 ~ 30 mL of blood.

Precautions

This medication is very potent and should only be used under strict supervision of a physician. Use with caution in patients with diseases that have a high risk of bleeding, as bleeding may occur in nearly all areas of the body after administration. Care should be taken as severe cases may result in fatal hemorrhage. It contains a component called benzyl alcohol, which can be very dangerous for premature infants or newborns. Patients who have had allergic reactions to this medication or its components should not use it, and those with inappropriate blood coagulation test results should also refrain from administration. It is contraindicated in patients with significant bleeding, those with a tendency to bleed, severe liver or kidney diseases, and those who have recently undergone neurosurgery or eye surgery. Blood coagulation status should be frequently monitored during the administration of this medication to manage the risk of bleeding, and administration should be immediately stopped if bleeding symptoms appear. Heparin-induced thrombocytopenia may occur with a sharp decrease in platelet count, thus platelet counts should be periodically checked. This medication may interact with other drugs, so if other medications are being taken, consulting a healthcare provider is essential. Women who are pregnant or breastfeeding should use it cautiously considering the potential effects on the fetus or newborn. In cases of overdose, the risk of bleeding increases, so immediate treatment with the antidote protamine sulfate is required, and care must be taken for side effects even when using the antidote. Intramuscular injections are advisable to avoid due to the risk of hematomas, and it should not be mixed with antihistamines. Always follow the healthcare provider's instructions when using this medication, and report any unusual symptoms immediately.

Side effects

  • Hemorrhage
  • fatal hemorrhage
  • acute adrenal insufficiency
  • adrenal hemorrhage
  • ovarian hemorrhage
  • retroperitoneal hemorrhage
  • cerebral hemorrhage
  • thrombocytopenia
  • arterial and venous thrombosis
  • acute reversible thrombocytopathy
Show 41 more
  • elevated γ-GTP
  • elevated LDH
  • elevated AST
  • elevated ALT
  • itching
  • urticaria
  • chills
  • fever
  • rhinitis
  • bronchial asthma
  • tearing
  • conjunctivitis
  • cyanosis
  • tachycardia
  • pressure sensation
  • angioedema
  • nausea
  • vomiting
  • hypotension
  • dyspnea
  • bronchospasm
  • shock
  • hair loss
  • vitiligo
  • hemorrhagic necrosis
  • hypoaldosteronism
  • osteoporosis
  • rebound effect
  • dyslipidemia
  • renal function inhibition
  • localized painful hematoma
  • priapism
  • diabetes mellitus
  • hyperkalemia
  • hyperalkalemia
  • metabolic acidosis
  • elevated lipase
  • vascular spasm reaction
  • erythema
  • mild pain
  • ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, at a temperature between 1 to 30 degrees Celsius to maintain its efficacy and prevent deterioration.

Appearance and packaging

Appearance

A transparent liquid that is colorless to pale yellow contained in a brown vial

Package unit

5 milliliters × 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.